Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Disposal

2 Jan 2015 07:00

RNS Number : 9160A
IPPlus PLC
02 January 2015
 

For immediate release

2 January 2015

IPPlus PLC

("IPPlus" or the "Group")

Disposal

Agreed sale of Ancora Solutions to Restore PLC

IPPlus PLC (AIM: IPP), the Ipswich based services company covering call centre services, call centre software, archiving, disaster recovery, telephony and payment card industry ("PCI") compliant solutions, announces the disposal of the trade and assets of its data archiving business, Ancora Solutions ("Ancora"), a trading division within the IPPlus (UK) Limited subsidiary to Restore PLC ("Restore") for a total consideration of £500,000 in cash (the "Disposal").

Ancora operates primarily in London and the East of England. The business provides secure document removal, archiving, confidential data destruction and library move services to the medical and scientific industries, as well as industrial and professional sectors. In the financial year to 30 June 2014, Ancora reported revenue of approximately £732k and a loss of approximately £94k (including allocated central Group costs). The net book value of the assets being disposed of as at 30 June 2014 was approximately £325k.

As stated in the Group's last Annual Report and Accounts, the Board has been actively reviewing Ancora's operations. Following this review, the Board concluded that Ancora was non-core to the Group's contact centre service and software operations and that, as Ancora is relatively small in scale, an owner with a stronger presence in its sector could potentially derive more value from the business. Accordingly, the Board considers that the Disposal is in the best interests of the Group's shareholders. Completion of the sale will allow the Group to focus on its core activities of contact centre provision, call centre software and telephony and PCI compliant solutions, which delivered over 90 per cent. of Group revenues in the past financial year.

Under the terms of the Disposal, Restore has agreed to purchase the entire fixed assets, payroll and existing contracts of Ancora in return for cash consideration of £500,000. The Group intends to use the proceeds from the Disposal to strengthen its working capital position.

William Catchpole, Chief Executive Officer of IPPLUS, commented:

 

"This disposal is an important strategic step for the Group and allows us to focus on our core call centre and software activities as well as PCI-PAL, the Group's Level 1 accredited PCI compliant service."

For further information, please contact:

IPPLUS PLC

Tel: +44 (0)1473 321 800

William Catchpole, Chief Executive Officer

Stuart Gordon, Chief Financial Officer

 

N+1 Singer (Nominated Adviser & Broker)

Tel: +44 (0)20 7496 3000

Aubrey Powell / Alex Wright / Ben Griffiths

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISWGGAUPUPCGGU
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.